Skip to main content
Fresenius SE & Co. KGaA logo

Fresenius SE & Co. KGaA — Investor Relations & Filings

Ticker · FRE ISIN · DE0005785604 LEI · XDFJ0CYCOO1FXRFTQS51 F Human health and social work activities
Open in API
Filings indexed 1,397 across all filing types
Latest filing 2010-05-12 AGM Information
Country DE Germany
Listing F FRE

About Fresenius SE & Co. KGaA

https://www.fresenius.com/

Fresenius SE & Co. KGaA is a global healthcare company that provides system-critical products and services for leading therapies for the care of critically and chronically ill patients. The company's portfolio encompasses a wide range of products and services for dialysis, hospitals, and outpatient medical care. Key offerings include intravenously administered generic drugs, biopharmaceuticals, biosimilars, clinical nutrition, and infusion therapies. Additionally, the company operates a large network of private hospitals and outpatient centers. Through its strategic investment in Fresenius Medical Care, it is a leading global provider of products and services for individuals with renal diseases.

Recent filings

Filing Released Lang Actions
Präsentation - Hauptversammlung 2010
AGM Information Classification · 99% confidence The document is titled 'Hauptversammlung der Fresenius SE Herzlich Willkommen' (Annual General Meeting of Fresenius SE Welcome) and dated May 12, 2010. It contains an 'Agenda' covering 'Geschäftsentwicklung 2009' (Business Development 2009), Q1 2010 results, dividend proposals, and a section on 'Aktienumwandlung und Rechtsformwechsel' (Share conversion and change of legal form). The content is clearly material presented and discussed at an Annual General Meeting (AGM). This aligns perfectly with the AGM Information category.
2010-05-12 German
Q1 Report 2010
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Quarterly Financial Report of Fresenius Group' for the '1st Quarter 2010'. It contains comprehensive financial data, including consolidated statements of income, financial position, cash flows, segment reporting, and a detailed management report. It is not an announcement or a short summary, but the full interim report itself, fitting the definition of an Interim/Quarterly Report (IR). Q1 2010
2010-05-10 German
Declaration of Voting Results & Voting Rights Announcements 2010
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document explicitly states in the title and body that it is a 'Release according to Article 26, Section 1 of the WpHG' and a 'Voting Rights announcement'. It details changes in the percentage of voting rights held by specific entities (FMR LLC, Fidelity Management & Research Company, Fidelity Investment Trust) falling below the 3% threshold. This directly corresponds to the definition of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is short, but the content is the announcement itself, not a notice about an attached report.
2010-05-06 English
DGAP-DD: Fresenius SE english
Director's Dealing Classification · 100% confidence The document text explicitly contains the header 'Directors’ Dealings' and details a transaction (Purchase) made by a 'Member of a managing body' (Stephan Sturm) involving the company's ordinary shares. This directly matches the definition for Director's Dealing, which corresponds to the filing code DIRS.
2010-05-05 English
Analyst Meeting - Q1/2010 Results
Investor Presentation Classification · 98% confidence The document is titled "Analyst Meeting – Q1/10 Results" and contains detailed financial tables, segment updates (Fresenius Kabi, Helios, Vamed), and a Profit and Loss Statement for Q1/10. This structure strongly indicates a presentation or detailed report summarizing quarterly financial performance. Since it is a presentation format (indicated by the title 'Analyst Meeting' and the structure resembling slides) detailing comprehensive quarterly results, it aligns best with an Investor Presentation (IP) rather than just an Earnings Release (ER) which is typically just the highlights, or an Interim Report (IR) which is usually a formal regulatory filing document. The date is May 4, 2010, reporting on Q1/10 results, confirming it is a period-specific financial review.
2010-05-05 English
Fresenius SE: Bekanntmachung der Einberufung zur Hauptversammlung am 12.05.2010 in Frankfurt am Main mit dem Ziel der europaweiten Verbreitung gema 121 AktG
AGM Information Classification · 98% confidence The document is titled 'Bekanntmachung der Einberufung zur Hauptversammlung' (Announcement of the Convocation to the General Meeting) and explicitly details the agenda ('Tagesordnung') for a meeting scheduled for May 12, 2010. The agenda includes items typical for an Annual General Meeting (AGM), such as presenting the annual financial statements, voting on profit distribution (dividends), discharging the board and supervisory board, and voting on a major corporate restructuring (conversion from SE to KGaA). The document is a formal notice inviting shareholders to the meeting, which aligns perfectly with the definition of an AGM-related document, specifically the notice/convocation itself. Although it contains detailed financial/governance proposals, its primary function is to convene the meeting. Therefore, the most appropriate code is AGM-R.
2010-04-01 German

Browse filings by year

31 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.